Folate analogues. 31. Synthesis of the reduced derivatives of 11-deazahomofolic acid, 10-methyl-11-deazahomofolic acid, and their evaluation as inhibitors of glycinamide ribonucleotide formyltransferase.
Folate analogues. 31. Synthesis of the reduced derivatives of 11-deazahomofolic acid, 10-methyl-11-deazahomofolic acid, and their evaluation as inhibitors of glycinamide ribonucleotide formyltransferase.
复制标题
叶酸类似物。
DOI:
10.1021/jm00126a022
复制
发表时间:
1989
影响因子:
7.3
通讯作者:
Edelstein,MP
中科院分区:
文献类型:
--
作者:
Nair,MG;Murthy,BR;Patil,SD;Kisliuk,RL;Thorndike,J;Gaumont,Y;Ferone,R;Duch,DS;Edelstein,MP
The Boon-Leigh procedure, involving condensation of a 6-chloro-5-nitropyrimidine (22) with an-amino ketone (20 or 21) followed by reduction of the nitro group, cyclization, and L-glutamylation, led to the formation of 11-deazahomofolate (29) and its 10-methyl derivative (30). The corresponding (6fi, S)-5, 6, 7, 8-tetrahydro (4, 5) and 7, 8-dihydro (31, 32) derivatives were prepared by catalytic hydrogenation.(6S)-11-Deazatetrahydrohomofoíate was prepared from 29 by enzymatic reduction. Compounds 29 and 30 had little effect (IC50> 2 X 10" 6 M) on Lactobacillus casei glycinamide ribonucleotide (GAR) formyltransferase but (6R, S)-ll-deazatetrahydrohomofolate (4) is a potent inhibitor of this enzyme (ICM= 5 X 10 “8 M). It is at least 100 times more inhibitory than 33, the 6S compound, indicating that the 6R component of the mixture having the unnatural configuration at C6 (34) is responsible for the potent inhibition. Compound 4 is a much weaker inhibitor of murine (L1210) and human (MOLT-4) leukemia cell GAR formyltransferases (IC^> 1 X 10" 5 M).(6fi, S)-11-Deaza-10-methyltetrahydrohomofolate (5)(IC50= LI